Molecular docking and dynamics studies on novel benzene sulfonamide substituted pyrazole-pyrazoline analogues as potent inhibitors of Plasmodium falciparum Histo aspartic protease.
Malaria is the major health issue in African, Asian and Mediterranean regions of the world. Due to the emerging resistance by the parasites and mosquitoes for the current medications and insecticides, respectively, the malaria free human world can be attained only by the novel design and development of new anti-malarial drugs. Hence, we attempted to carry out in silico screening of benzene sulfonamide substituted pyrazole-pyrazoline series against Histo aspartic protease. Our results reveal that the 65% of the data set with the free binding energy in the range of -11.58 to -11.21 kcal/mol, which is categorized as 'high scoring'. Ligands are docked with the catalytic residues Asp 215, Ser 75, Thr 33 and Ala 217, respectively. Molecular dynamic simulation study of free enzyme and the enzyme complex with 4-(5-(4-methoxyphenyl)-1'phenyl-3'-(p-tolyl)-3,4-1'H,2H-[3,4'-bipyrazol]-2-yl)benezenesulfonamide indicated structural stability. The trajectory analysis of complex reveals that the HAP-ligand complex is more stable than the free HAP. We are of the opinion that our results will be useful for designing potential anti-malarial compounds. Abbreviations ADT auto dock tools BSPP benzene sulfonamide substituted pyrazole-pyrazoline CQ chloroquine HAP histo aspartic protease K Kelvin MD molecular docking MM/PBSA molecular mechanics/Poisson Boltzmann surface area NVT normal volume and temperature NPT normal pressure and temperature Ns nanoseconds PDB protein data bank .pdb program data base format P. falciparum Plasmodium falciparum Ps picoseconds PMs plasmepsins P. vivax Plasmodium vivax Rg radius of gyration RMSD root mean square deviation RMSF root mean square fluctuation WHO World Health Organization Communicated by Ramaswamy H. Sarma.